Effect of pain and nonsteroidal analgesics on blood pressure

Wisconsin Medical Journal

Volumn 98, Issue 6, 1999, Pages

  Chawla, Paramjith S ^a   Kochar, Mahendr S ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; DEXTROPROPOXYPHENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETODOLAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYLBUTAZONE; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; ROFECOXIB; SULINDAC; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CHRONIC PAIN; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG MECHANISM; ELDERLY CARE; HUMAN; HYPERTENSION; PHYSIOTHERAPY; PROSTAGLANDIN SYNTHESIS; REVIEW; SODIUM RETENTION; SYMPATHETIC TONE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; CHRONIC DISEASE; HUMANS; HYPERTENSION; PAIN;

EID: 6544294068     PISSN: 00436542     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Schobel HP, Ringkamp M, Behrmann A et al Hemodynamic and sympathetic nerve responses to painful stimuli in normotensive and borderline hypertensive subjects Pain 1996; 66: 117-24.
2. Akil H. and Liebeskind JC. Monoaminergic mechanisms of stimulation-produced analgesia Brain Research 1975, 94 279-96.
3. Chalmers PJ. Brain amines and models of experimental hypertension Circulat Res 1975; 36:469-80.
4. Scriabine A, Clineschmidt BV, Sweet CS. Central noradrenergic control of blood pressure. Ann Rev Pharmocol Toxicol 1976; 16 :113-23.
5. Buscher HH, Hill RC, Romer D and Cardinaux F et al Evidence for analgesic activity of enkephalin in the mouse. Nature (Lond.). 1976; 261 :423-25.
6. Florez J and Mediavilla A. Respiratory and cardiovascular effects of met-enkephalin applied to the ventral surface of the brain stem Brain Research 1977; 138: 585-90
7. Lemaire I, Tseng R and Lemaire S. Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway. Proc Nat Acad Sci (Wash.) 1978; 75:6240-42.
8. Paalzow L. Analgesia produced by clonidine in mice and rats. J Pharm Pharmacol 1974, 26:361-63
9. Johnson AG. NSAIDs and increased blood pressure. Drug Safety. 1997;17(5):277-89.
10. Houston MC. Nonsteroidal anti-inflammatory drugs and antihypertensives Am J Med 1991; 90 (suppl 5A):42S-7S.
11. Simon IS. Actions and toxity of nonsteroidal anti-inflammatory drugs. Curr Opin Rhematol 1995;7:159-66.
12. Mitchell JA, Akaresereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA. 1993; 90 :11693-7
13. Polisson R Nonsteroidal anti-inflammatory drugs. Practical and theoritical considerations in their selection. Am J Med. 1996 ,100 suppl 2A :31S-6S.
14. Quilley J, McGiffJC Eicosanoids In Swales JD, editor. Textbook of hypertension. Oxford Blackwell Scientific Publications 1994; 314-27.
15. Wennmalm A Influence of indomethacin on the systemic and pulmonary vascular resistence in man. Clin Sci Mol Med 1978, 54:141-45
16. Nowak J, Wennmalm A Influence of indomethacin and of prostaglandin E 1 on total and regional blood flow in man. Acta Physiol Scand. 1978;102:484-91.
17. Negus P, Tannen RL, Dunn MJ. Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man. Prostaglandins 1976, 12:175-80.
18. Sedor JR, Williams SL, Chremos AW, et al Effects of sulindac and indomethacin on renal prostaglandin synthesis. Clin Pharmacol Ther 1984; 36 85-91.
19. Silverstein ME, Iieldman RC, Henderson LW, Engelman K. Acute effects of indomethacin and aspirin on human renal function Clin Res 1975;23: 374a.
20. Johnson AG, Nguyen TV, Owe-Young R, et al. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin 1 J Hum Hypertens 1996; 10:257-61.
21. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure Relation to activation of the renin-angiotensin system and hyponatremia N Eng J Med 1984;310:347-52.
22. Abraham PA, Keane WF Glomerular and interstitial diseases induced by nonsteroidal anti-inflammatory drugs. Am J Nephrol 1984, 4:1-6.
23. Hawker G. Prescribing nonsteroidal anti-inflammatory drugs-what's new ? The Jour of Rheum. 1997;24:(2).243-5.
24. Noble S, Balfour JA. Meloxicam Drugs 1996; 51 (3):424-30.
25. Wing LM. NSAIDs- Interactions with antihypertensives and diuretics In Brooks P, Day RO, editors. Nonsteroidal anti-inflammatory drugs Basis for variability in response. Basel Birkhauser Verlag. 1985:91-7.
26. Koopmans PP. Pathophysiological and clinical aspects of the infraction between nonsteroidal anti-inflammatory drugs and diuretics. Neth J Med 1985;28(11):524-9.
27. Kirchner KA, Brandon S, Muellar RA, et al. Mechanism of attenuated hydrochlorothiazide response during indomethacin administration Kidney Int 1987;31 (5):1097-103.
28. Wong DG, Spence JD, Lamki L, et al. Effect of nonsteroidal anti-inflammatory drugs on control of hypertension by bera-blockers and diuretics. Lancet 1986; 1:997-1001.
29. Sturrock ND, Struthers AD. Nonsteroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function. Br J Clin Pharmacol 1993, 35(4):343-8.
30. Houston MC, Weir M, Gray J, et al. The effects of nonsteroidal anti-inflammatory drugs on blood pressure of patients with hypertension controlled by verapamil. Arch Intern Med 1995,155:1049-54.
31. Takeuchi K, Abe K, Yasujima M, et al. No adverse effect of nonsteroidal antiinflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients. Tohoku J Exp Med 1991; 165:201-8
32. Hardy BG, Bartle WR, Myers M, Bailey DG, Edgar B.Effects of indomethacin on the pharmacokinetics of felodipine. Br J Clin Pharmacol 1988, 26:557-67
33. Rubin P, Jackson G, Blashke T. Studies of the clinical pharmacology of prazosin: The influence of iridomethacin and of propranolol on the action and disposition of prazosin. Br J Clin Pharmacol 1980; 10 33-9.
34. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsterodial anti-inflammatory drugs on blood pressure, Arch Intern Med 1993; 153:477-84.
35. Johnson AG, Nguyen TV, Day RO Do nonsteroidal anti-infalmmatory drugs affect blood pressure? Ann Intern Med 1994;121:289-300.
36. Collins R, Peto R, MacMohan S. et al. Epidemiology. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-38
37. Chrischilles EA, Wallace RB. Nonsteroidal anti-inflammatory drugs and blood pressure in elderly population. J Gereontol 1993,48:M 91-6.
38. Ferri C, Bellini C, Picolli A, et al. Enhanced blood pressure response to cyclooxygensase inhibition in salt-sensitive human essential hypertension. Hypertension 1993,21: 875-81.
39. Gurwitz JH, Avorn J, Bohn RL, et al., Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994, 272:781-6.